Our mission
The blood-brain barrier (BBB) acts as a critical defense mechanism against harmful substances. However, this selectivity also impedes the delivery of therapeutic agents to the brain, a significant challenge in treating neurological disorders.
TheraSonic non-invasive device transiently disrupts the BBB using low-intensity focused ultrasound which facilitates the delivery of therapeutics at targeted locations in the brain.
Breakthrough in Brain Drug Delivery
Backed by over 15 years of academic research, this innovative technology enables non-invasive delivery of therapeutics to targeted areas of the brain.
-
Safety
Our real-time dosimetry solution ensures safe disruption of the blood-brain barrier using focused ultrasound for repeated treatments.
-
Accuracy
Based on state-of-the-art neuro-navigation solution, our system ensures precise targeting in the brain.
-
Multiple targets and volumes
Leveraging our medical robot technology, our platform enables treatment of multiple targets and large volume in a single session.
News
- September 2024 Therasonic to participate at the Annual Symposium on Therapeutic Ultrasound at Taipei, Taiwan
- September 2024 TheraSonic participates to Robotique Medicale Made In France Conference
- May 2024 Therasonic selected to pitch Oncology Upward Investment
- May 2024 TheraSonic raises preseed round
- April 2024 TheraSonic will participate to Saclay Spring50